We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Could Extracellular Vesicles be Personalized Drug Delivery Vehicles?

News   Mar 13, 2018 | Original story from Penn State

 
Could Extracellular Vesicles be Personalized Drug Delivery Vehicles?

This image shows ligands-grafted extracellular vesicles as drug delivery vehicles. Credit: Xin Zou

 
 
 

RELATED ARTICLES

First Bioprinted Organ in Space

News

Russian astronauts onboard a spacecraft have reportedly bioprinted a mouse thyroid. This is definitely a world-first in outer space bioprinting.

READ MORE

New Imaging Tools that Trace Key Breast Cancer Enzymes May Help Guide Therapies

News

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

READ MORE

Cancer Vaccine Progress: Potentially Rich Source of Tumor Specific Antigens Identified

News

The immunogenicity and efficacy of tumor specific antigen vaccination for select antigens has been validated in mouse models of cancer. The researchers believe that clinical trials for human cancer vaccines could start within the next 2-3 years.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE